Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section
Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
Our aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine
0.25% alone in transversus abdominis plane (TAP) block for postoperative analgesia in
patients undergoing an elective Caesarean section.
- Group 1: bupivacaine 0.25% + dexamethasone 8 mg
- Group 2: bupivacaine 0.25% A prospective Randomized Interventional double-blind study.